上方“瞪羚社”即刻关注并加入社群聚焦高成长公司,100000+投资菁英共同关注昨晚,一场爆炸性的收购刷爆了大部分行业内人士的朋友圈。中国生物制药7月15日盘后发布公告称,中国生物制药同意以不超过9.5亿美元(约68亿元人民币)对价,收购礼新医药95.09%股权。剔除礼新医药于交割日的估计现金及银行存款约4.5亿美元,中国生物制药就收购事项待作出的付款净额约为5亿美元。这起交易,毫无疑问中国生物制药...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.